Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.

Jones IC, Espindola MS, Narayanan R, Coelho AL, Habiel DM, Boehme SA, Ly TW, Bacon KB, Hogaboam CM.

Sci Rep. 2019 Dec 24;9(1):19796. doi: 10.1038/s41598-019-56393-z.

2.

DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis.

Habiel DM, Hohmann MS, Espindola MS, Coelho AL, Jones I, Jones H, Carnibella R, Pinar I, Werdiger F, Hogaboam CM.

BMC Pulm Med. 2019 Aug 29;19(1):165. doi: 10.1186/s12890-019-0922-7.

3.

Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles.

Parimon T, Yao C, Habiel DM, Ge L, Bora SA, Brauer R, Evans CM, Xie T, Alonso-Valenteen F, Medina-Kauwe LK, Jiang D, Noble PW, Hogaboam CM, Deng N, Burgy O, Antes TJ, Königshoff M, Stripp BR, Gharib SA, Chen P.

JCI Insight. 2019 Aug 8;5. pii: 129359. doi: 10.1172/jci.insight.129359.

4.

CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.

Palchevskiy V, Xue YY, Kern R, Weigt SS, Gregson AL, Song SX, Fishbein MC, Hogaboam CM, Sayah DM, Lynch JP 3rd, Keane MP, Brooks DG, Belperio JA.

JCI Insight. 2019 May 14;5. pii: 121782. doi: 10.1172/jci.insight.121782.

5.

PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.

Geng Y, Liu X, Liang J, Habiel DM, Kulur V, Coelho AL, Deng N, Xie T, Wang Y, Liu N, Huang G, Kurkciyan A, Liu Z, Tang J, Hogaboam CM, Jiang D, Noble PW.

JCI Insight. 2019 Mar 21;4(6). pii: 125326. doi: 10.1172/jci.insight.125326. eCollection 2019 Mar 21.

6.

Characterization of CD28null T cells in idiopathic pulmonary fibrosis.

Habiel DM, Espindola MS, Kitson C, Azzara AV, Coelho AL, Stripp B, Hogaboam CM.

Mucosal Immunol. 2019 Jan;12(1):212-222. doi: 10.1038/s41385-018-0082-8. Epub 2018 Oct 12.

7.

Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts.

Schuliga M, Pechkovsky DV, Read J, Waters DW, Blokland KEC, Reid AT, Hogaboam CM, Khalil N, Burgess JK, Prêle CM, Mutsaers SE, Jaffar J, Westall G, Grainge C, Knight DA.

J Cell Mol Med. 2018 Dec;22(12):5847-5861. doi: 10.1111/jcmm.13855. Epub 2018 Sep 26.

8.

Notch signaling regulates cell density-dependent apoptosis of NIH 3T3 through an IL-6/STAT3 dependent mechanism.

Matsuno Y, Kiwamoto T, Morishima Y, Ishii Y, Hizawa N, Hogaboam CM.

Eur J Cell Biol. 2018 Sep;97(7):512-522. doi: 10.1016/j.ejcb.2018.09.001. Epub 2018 Sep 12.

9.

Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice.

Skalski JH, Limon JJ, Sharma P, Gargus MD, Nguyen C, Tang J, Coelho AL, Hogaboam CM, Crother TR, Underhill DM.

PLoS Pathog. 2018 Sep 20;14(9):e1007260. doi: 10.1371/journal.ppat.1007260. eCollection 2018 Sep.

10.

CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling.

Habiel DM, Espindola MS, Jones IC, Coelho AL, Stripp B, Hogaboam CM.

JCI Insight. 2018 Aug 23;3(16). pii: 122211. doi: 10.1172/jci.insight.122211. eCollection 2018 Aug 23.

11.

Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.

Hohmann MS, Habiel DM, Coelho AL, Verri WA Jr, Hogaboam CM.

Am J Respir Cell Mol Biol. 2019 Jan;60(1):28-40. doi: 10.1165/rcmb.2017-0289OC.

12.

Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells.

Cavassani KA, Meza RJ, Habiel DM, Chen JF, Montes A, Tripathi M, Martins GA, Crother TR, You S, Hogaboam CM, Bhowmick N, Posadas EM.

Cancer Med. 2018 Sep;7(9):4639-4649. doi: 10.1002/cam4.1695. Epub 2018 Aug 9.

13.

Reply to D'Alessandro-Gabazza et al.: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.

Espindola MS, Habiel DM, Hogaboam CM.

Am J Respir Crit Care Med. 2018 Oct 1;198(7):971-973. doi: 10.1164/rccm.201805-0972LE. No abstract available.

14.

Diabetes Downregulates Allergen-Induced Airway Inflammation in Mice.

Carvalho VF, Barreto EO, Arantes ACS, Serra MF, Ferreira TPT, Jannini-Sá YAP, Hogaboam CM, Martins MA, Silva PMR.

Mediators Inflamm. 2018 Apr 15;2018:6150843. doi: 10.1155/2018/6150843. eCollection 2018.

15.

TRAIL-Dependent Resolution of Pulmonary Fibrosis.

Habiel DM, Moreira AP, Ismailoglu UB, Dunleavy MP, Cavassani KA, van Rooijen N, Coelho AL, Hogaboam CM.

Mediators Inflamm. 2018 Jan 24;2018:7934362. doi: 10.1155/2018/7934362. eCollection 2018.

16.

Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.

Espindola MS, Habiel DM, Narayanan R, Jones I, Coelho AL, Murray LA, Jiang D, Noble PW, Hogaboam CM.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1443-1456. doi: 10.1164/rccm.201707-1519OC.

17.

Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis.

Griffiths K, Habiel DM, Jaffar J, Binder U, Darby WG, Hosking CG, Skerra A, Westall GP, Hogaboam CM, Foley M.

Sci Rep. 2018 Feb 16;8(1):3212. doi: 10.1038/s41598-018-20811-5.

18.

Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Hartl D, Tirouvanziam R, Laval J, Greene CM, Habiel D, Sharma L, Yildirim AÖ, Dela Cruz CS, Hogaboam CM.

J Innate Immun. 2018;10(5-6):487-501. doi: 10.1159/000487057. Epub 2018 Feb 13. Review.

19.

Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.

Habiel DM, Espindola MS, Coelho AL, Hogaboam CM.

Am J Pathol. 2018 Apr;188(4):891-903. doi: 10.1016/j.ajpath.2017.12.020. Epub 2018 Feb 17.

20.

Syndecan-1 Controls Lung Tumorigenesis by Regulating miRNAs Packaged in Exosomes.

Parimon T, Brauer R, Schlesinger SY, Xie T, Jiang D, Ge L, Huang Y, Birkland TP, Parks WC, Habiel DM, Hogaboam CM, Gharib SA, Deng N, Liu Z, Chen P.

Am J Pathol. 2018 Apr;188(4):1094-1103. doi: 10.1016/j.ajpath.2017.12.009. Epub 2018 Jan 31.

21.

Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.

Cooke G, Kamal I, Strengert M, Hams E, Mawhinney L, Tynan A, O'Reilly C, O'Dwyer DN, Kunkel SL, Knaus UG, Shields DC, Moller DR, Bowie AG, Fallon PG, Hogaboam CM, Armstrong ME, Donnelly SC.

QJM. 2018 Apr 1;111(4):217-224. doi: 10.1093/qjmed/hcx243.

22.

Divergent roles for Clusterin in Lung Injury and Repair.

Habiel DM, Camelo A, Espindola M, Burwell T, Hanna R, Miranda E, Carruthers A, Bell M, Coelho AL, Liu H, Pilataxi F, Clarke L, Grant E, Lewis A, Moore B, Knight DA, Hogaboam CM, Murray LA.

Sci Rep. 2017 Nov 13;7(1):15444. doi: 10.1038/s41598-017-15670-5.

23.

Recognition of Candida albicans by gingival fibroblasts: The role of TLR2, TLR4/CD14, and MyD88.

Pinheiro CR, Coelho AL, de Oliveira CE, Gasparoto TH, Garlet GP, Silva JS, Santos CF, Cavassani KA, Hogaboam CM, Campanelli AP.

Cytokine. 2018 Jun;106:67-75. doi: 10.1016/j.cyto.2017.10.013. Epub 2017 Nov 9.

24.

Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.

Habiel DM, Hogaboam CM.

Curr Pathobiol Rep. 2017 Jun;5(2):101-110. doi: 10.1007/s40139-017-0134-x. Epub 2017 May 2.

25.

Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis.

Murray LA, Habiel DM, Hohmann M, Camelo A, Shang H, Zhou Y, Coelho AL, Peng X, Gulati M, Crestani B, Sleeman MA, Mustelin T, Moore MW, Ryu C, Osafo-Addo AD, Elias JA, Lee CG, Hu B, Herazo-Maya JD, Knight DA, Hogaboam CM, Herzog EL.

JCI Insight. 2017 Aug 17;2(16). pii: 92192. doi: 10.1172/jci.insight.92192. eCollection 2017 Aug 17.

26.

Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium.

Murray LA, Dunmore R, Camelo A, Da Silva CA, Gustavsson MJ, Habiel DM, Hackett TL, Hogaboam CM, Sleeman MA, Knight DA.

Respir Res. 2017 May 3;18(1):82. doi: 10.1186/s12931-017-0565-2.

27.

Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.

Huang Y, Ma SF, Espindola MS, Vij R, Oldham JM, Huffnagle GB, Erb-Downward JR, Flaherty KR, Moore BB, White ES, Zhou T, Li J, Lussier YA, Han MK, Kaminski N, Garcia JGN, Hogaboam CM, Martinez FJ, Noth I; COMET-IPF Investigators.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):208-219. doi: 10.1164/rccm.201607-1525OC.

28.

miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways.

Ge L, Habiel DM, Hansbro PM, Kim RY, Gharib SA, Edelman JD, Königshoff M, Parimon T, Brauer R, Huang Y, Allen J, Jiang D, Kurkciyan AA, Mizuno T, Stripp BR, Noble PW, Hogaboam CM, Chen P.

JCI Insight. 2016 Dec 8;1(20):e90301. doi: 10.1172/jci.insight.90301.

29.

Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.

Habiel DM, Krepostman N, Lilly M, Cavassani K, Coelho AL, Shibata T, Elenitoba-Johnson K, Hogaboam CM.

Oncotarget. 2016 Dec 13;7(50):83514-83529. doi: 10.18632/oncotarget.13158.

30.

Double-Stranded RNA Interacts With Toll-Like Receptor 3 in Driving the Acute Inflammatory Response Following Lung Contusion.

Suresh MV, Thomas B, Machado-Aranda D, Dolgachev VA, Kumar Ramakrishnan S, Talarico N, Cavassani K, Sherman MA, Hemmila MR, Kunkel SL, Walter NG, Hogaboam CM, Raghavendran K.

Crit Care Med. 2016 Nov;44(11):e1054-e1066.

31.

Neonatal monocytes exhibit a unique histone modification landscape.

Bermick JR, Lambrecht NJ, denDekker AD, Kunkel SL, Lukacs NW, Hogaboam CM, Schaller MA.

Clin Epigenetics. 2016 Sep 20;8:99. doi: 10.1186/s13148-016-0265-7. eCollection 2016.

32.

Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.

Nie Z, Du MQ, McAllister-Lucas LM, Lucas PC, Bailey NG, Hogaboam CM, Lim MS, Elenitoba-Johnson KS.

Nat Commun. 2015 Jan 8;6:5908. doi: 10.1038/ncomms6908.

PMID:
25569716
33.

Gas6'ing the innate immune response during experimental asthma.

Shibata T, Hogaboam CM.

Ann Am Thorac Soc. 2014 Dec;11 Suppl 5:S303-5. doi: 10.1513/AnnalsATS.201401-013AW.

PMID:
25525737
34.

Axl receptor blockade protects from invasive pulmonary aspergillosis in mice.

Shibata T, Habiel DM, Coelho AL, Hogaboam CM.

J Immunol. 2014 Oct 1;193(7):3559-65. doi: 10.4049/jimmunol.1401258. Epub 2014 Aug 25.

35.

Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair.

Prasad S, Hogaboam CM, Jarai G.

Fibrogenesis Tissue Repair. 2014 Apr 29;7:7. doi: 10.1186/1755-1536-7-7. eCollection 2014.

36.

Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice.

Shibata T, Ismailoglu UB, Kittan NA, Moreira AP, Coelho AL, Chupp GL, Kunkel SL, Lukacs NW, Hogaboam CM.

Am J Respir Cell Mol Biol. 2014 Nov;51(5):615-25. doi: 10.1165/rcmb.2014-0049OC.

37.

Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.

Ellson CD, Dunmore R, Hogaboam CM, Sleeman MA, Murray LA.

Am J Respir Cell Mol Biol. 2014 Aug;51(2):163-8. doi: 10.1165/rcmb.2013-0366TR. Review.

PMID:
24749648
38.

Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

Shibata T, Habiel DM, Coelho AL, Kunkel SL, Lukacs NW, Hogaboam CM.

J Immunol. 2014 Apr 15;192(8):3569-81. doi: 10.4049/jimmunol.1302766. Epub 2014 Mar 21.

39.

Role of Th1/Th17 balance regulated by T-bet in a mouse model of Mycobacterium avium complex disease.

Matsuyama M, Ishii Y, Yageta Y, Ohtsuka S, Ano S, Matsuno Y, Morishima Y, Yoh K, Takahashi S, Ogawa K, Hogaboam CM, Hizawa N.

J Immunol. 2014 Feb 15;192(4):1707-17. doi: 10.4049/jimmunol.1302258. Epub 2014 Jan 20.

40.

Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.

Santulli-Marotto S, Boakye K, Lacy E, Wu SJ, Luongo J, Kavalkovich K, Coelho A, Hogaboam CM, Ryan M.

PLoS One. 2013 Dec 5;8(12):e81465. doi: 10.1371/journal.pone.0081465. eCollection 2013.

41.

Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.

Murray LA, Zhang H, Oak SR, Coelho AL, Herath A, Flaherty KR, Lee J, Bell M, Knight DA, Martinez FJ, Sleeman MA, Herzog EL, Hogaboam CM.

Am J Respir Cell Mol Biol. 2014 May;50(5):985-94. doi: 10.1165/rcmb.2013-0342OC.

42.

Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes.

Kittan NA, Allen RM, Dhaliwal A, Cavassani KA, Schaller M, Gallagher KA, Carson WF 4th, Mukherjee S, Grembecka J, Cierpicki T, Jarai G, Westwick J, Kunkel SL, Hogaboam CM.

PLoS One. 2013 Oct 21;8(10):e78045. doi: 10.1371/journal.pone.0078045. eCollection 2013.

43.

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE Jr, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP.

Am J Respir Crit Care Med. 2014 Jan 15;189(2):214-22. doi: 10.1164/rccm.201306-1141WS.

44.

IL-13 immunotoxin accelerates resolution of lung pathological changes triggered by silica particles in mice.

Ferreira TP, de Arantes AC, do Nascimento CV, Olsen PC, Trentin PG, Rocco PR, Hogaboam CM, Puri RK, Martins MA, Silva PM.

J Immunol. 2013 Nov 15;191(10):5220-9. doi: 10.4049/jimmunol.1203551. Epub 2013 Oct 16.

45.

The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

O'Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, Simpson AJ, Millar AB, McGrath EE, Whyte MK, Hirani N, Hogaboam CM, Donnelly SC.

Am J Respir Crit Care Med. 2013 Dec 15;188(12):1442-50. doi: 10.1164/rccm.201304-0760OC.

PMID:
24070541
46.

Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.

Damjanovic D, Lai R, Jeyanathan M, Hogaboam CM, Xing Z.

Am J Pathol. 2013 Sep;183(3):868-80. doi: 10.1016/j.ajpath.2013.05.016. Epub 2013 Jul 4.

47.

Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma.

McDonnell SR, Hwang SR, Rolland D, Murga-Zamalloa C, Basrur V, Conlon KP, Fermin D, Wolfe T, Raskind A, Ruan C, Jiang JK, Thomas CJ, Hogaboam CM, Burant CF, Elenitoba-Johnson KS, Lim MS.

Blood. 2013 Aug 8;122(6):958-68. doi: 10.1182/blood-2013-01-482026. Epub 2013 Jun 27.

48.

MHV68 latency modulates the host immune response to influenza A virus.

Saito F, Ito T, Connett JM, Schaller MA, Carson WF 4th, Hogaboam CM, Rochford R, Kunkel SL.

Inflammation. 2013 Dec;36(6):1295-303. doi: 10.1007/s10753-013-9668-1.

49.

Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs.

Skjøt-Arkil H, Clausen RE, Rasmussen LM, Wang W, Wang Y, Zheng Q, Mickley H, Saaby L, Diederichsen AC, Lambrechtsen J, Martinez FJ, Hogaboam CM, Han M, Larsen MR, Nawrocki A, Vainer B, Krustrup D, Bjørling-Poulsen M, Karsdal MA, Leeming DJ.

PLoS One. 2013 Jun 21;8(6):e60936. doi: 10.1371/journal.pone.0060936. Print 2013.

50.

Toll like receptor 3 plays a critical role in the progression and severity of acetaminophen-induced hepatotoxicity.

Cavassani KA, Moreira AP, Habiel D, Ito T, Coelho AL, Allen RM, Hu B, Raphelson J, Carson WF 4th, Schaller MA, Lukacs NW, Omary MB, Hogaboam CM, Kunkel SL.

PLoS One. 2013 Jun 7;8(6):e65899. doi: 10.1371/journal.pone.0065899. Print 2013.

Supplemental Content

Loading ...
Support Center